US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED
Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
41 42 Next >
News headline image
The "Multi-Bagger" Portfolio Update: Week Ending January 27 ↗
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but many of them could possibly bounce back with major returns in 2023. We track the performance of a basket of 10 such... 
Via Talk Markets
News headline image
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD ↗
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. 
Via Talk Markets
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 26, 2023 ↗
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Virtual R&D Day
Via Investor Brand Network
Psychedelic Stock Gainers And Losers From January 17, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023 ↗
 
Via Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
News headline image
Cybin to Host Virtual R&D Day on February 28, 2023
From Cybin Inc.
Via Business Wire
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More ↗
Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First? 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 23, 2023 ↗
 
Via Benzinga
News headline image
Largest Psychedelic Stocks +3% This Week; Now +15% YTD ↗
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different... 
Via Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023 ↗
 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain ↗
Cybin Inc. 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study
Via Investor Brand Network
News headline image
Cybin Announces Promising Results from Sponsored Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
From Cybin Inc.
Via Business Wire
News headline image
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More ↗
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
Via Benzinga
News headline image
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment ↗
Life sciences biotech company Cybin Inc. (NYSE: CYBN) announced its selection of the Generalized Anxiety Disorder (GAD) with or without Major Depressive Disorder (MDD) as the target indication for its... 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
A "Multi-Bagger" Portfolio For 2023 - Introduction ↗
I am optimistic that the market will perform better in 2023 so I've put together a basket of 10 stocks that could well realize multi-bagger returns this year. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From January 13, 2023 ↗
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Selects Generalized Anxiety Disorder as Target Indication for CYB004
Via Investor Brand Network
News headline image
Cybin Selects Generalized Anxiety Disorder as Target Indication for Deuterated DMT Molecule CYB004
From Cybin Inc.
Via Business Wire
News headline image
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine... 
Via Benzinga
News headline image
Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket ↗
Gainers Broadwind, Inc. (NASDAQ: BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine... 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
41 42 Next >